Treatment of reduced bone mineral density in athletic amenorrhea: A pilot study

There is considerable concern about the adverse effects on the skeleton of loss of menstrual function as a result of athletic activity, as well as unc ertainty as to how it should be managed clinically. In a pilot intervention study 34 elite middle and long-distance runners, aged 18-35 years, with me nstrual irregularity due to their athletic activity were randomized to thre e groups: (A) to receive hormone replacement therapy (HRT) and 1000 mg calc ium per day (n = 10), (B) to receive 1000 mg calcium per day (n = 14), (C) a control group who received no treatment (n = 10). Bone mineral density (B MD) was measured in the left hip and lumbar spine (L2-4) using dual-energy X-ray absorptiometry. Results were first analyzed according to whether mens truation returned, either naturally or secondary to HRT (EU), and compared with those from subjects who remained amenorrheic (AM). During the first ye ar BMD increased in the EU,group in Ward's triangle (3.8%) and the lumbar s pine (4.1%; both P<0.05). BMD fell in the AM group in all regions and the b etween-group differences were 5.6% (p<0.02) in Ward's triangle, 5.8% (p<0.0 2) in L2-4 and 3.9% in the trochanter (p<0.05). An 'intention to treat' ana lysis was then performed. It was found that the mean relative improvement a t I year in spinal BMD was only 1.5%, due to return of menses in some of th e controls and withdrawals from treatment in the treatment group. In conseq uence, a trial designed to show, with 80% power and 5% si,significance, a m easurable benefit in lumbar spine BMD resulting from allocation to HRT trea tment would require about 1150 athletes with amenorrhea or oligomenorrhea. These numbers could be reduced substantially to 380 subjects by confining t he trial to completely amenorrheic athletes, who in this study were less li kely to regain menses. For these and other logistical reasons, an HRT trial in amenorrheic athletes could only be successfully organized through inter national collaboration. This study illustrates the major effects of treatme nt withdrawals and instability of menstrual status on the design of longitu dinal studies on the bony effects of menstrual dysfunction prior to menopau se.